The 2-Stage Liver Transplant: 3 Clinical Scenarios

dc.authoridToprak, Hüseyin İlksen/0000-0001-9293-8116
dc.authoridGedik, Ender/0000-0002-7175-207X
dc.authoridIsik, Burak/0000-0002-2395-3985
dc.authoridKayaalp, Cuneyt/0000-0003-4657-2998
dc.authorwosidToprak, Hüseyin İlksen/AAN-4023-2020
dc.authorwosidbıçakcıoğlu, murat/ABB-5579-2020
dc.authorwosidGedik, Ender/ABI-2971-2020
dc.authorwosidKayaalp, Cuneyt/AAH-1764-2021
dc.authorwosidIsik, Burak/A-6657-2018
dc.contributor.authorGedik, Ender
dc.contributor.authorBicakcioglu, Murat
dc.contributor.authorOtan, Emrah
dc.contributor.authorToprak, Huseyin Ilksen
dc.contributor.authorIsik, Burak
dc.contributor.authorAydin, Cemalettin
dc.contributor.authorKayaalp, Cuneyt
dc.date.accessioned2024-08-04T20:41:08Z
dc.date.available2024-08-04T20:41:08Z
dc.date.issued2015
dc.departmentİnönü Üniversitesien_US
dc.description14th Congress of the Middle-East-Society-for-Organ-Transplantation / 5th Middle East Transplant Games -- SEP 10-13, 2014 -- Istanbul, TURKEYen_US
dc.description.abstractThe main goal of 2-stage liver transplant is to provide time to obtain a new liver source. We describe our experience of 3 patients with 3 different clinical conditions. A 57-year-old man was retransplanted successfully with this technique due to hepatic artery thrombosis. However, a 38-year-old woman with fulminant toxic hepatitis and a 5-year-old-boy with abdominal trauma had poor outcome. This technique could serve as a rescue therapy for liver transplant patients who have toxic liver syndrome or abdominal trauma. These patients required intensive support during long anhepatic states. The transplant team should decide early whether to use this technique before irreversible conditions develop.en_US
dc.identifier.doi10.6002/ect.mesot2014.P135
dc.identifier.endpage289en_US
dc.identifier.issn1304-0855
dc.identifier.pmid25894175en_US
dc.identifier.scopus2-s2.0-84939814892en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage286en_US
dc.identifier.urihttps://doi.org/10.6002/ect.mesot2014.P135
dc.identifier.urihttps://hdl.handle.net/11616/96938
dc.identifier.volume13en_US
dc.identifier.wosWOS:000355058400059en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBaskent Univen_US
dc.relation.ispartofExperimental and Clinical Transplantationen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDeceased donoren_US
dc.subjectEnd-stage liver diseaseen_US
dc.subjectLiving donoren_US
dc.subjectRetransplanten_US
dc.subjectToxic liver syndromeen_US
dc.titleThe 2-Stage Liver Transplant: 3 Clinical Scenariosen_US
dc.typeConference Objecten_US

Dosyalar